Cash Flow Statement

Amortizatization of Intangibles Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Non-cash Items Other financing activities Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Sagimet Biosciences (SGMT) Gains from Sales and Divestitures (2024)

Sagimet Biosciences (SGMT) has 1 years of Gains from Sales and Divestitures data on record, last reported at $281458.0 in Q3 2024.